Immunic, Inc. (IMUX)
NASDAQ·Healthcare·Biotechnology
$7.80
—
Mkt Cap $111.32M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$32.00
Range $19.00 – $45.00
Implied Upside
+310.5%
Consensus $32.00 vs current $7.80
NASDAQ·Healthcare·Biotechnology
$7.80
—
Mkt Cap $111.32M
No recent rating data.
Price Target (5 analysts)
$32.00
Range $19.00 – $45.00
+310.5%
Consensus $32.00 vs current $7.80